Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies

References

• Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):1. doi:10.1186/s12929-019-0592-z. PMID: 31894001.
   PubMed Web of Science ®Google Scholar
• Reusch D, Tejada ML. Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology. 2015;25(12):1325–15. doi:10.1093/glycob/cwv065. PMID: 26263923.
   PubMed Web of Science ®Google Scholar
• Kunert R, Reinhart D. Advances in recombinant antibody manufacturing. Appl Microbiol Biotechnol. 2016;100(8):3451–61. doi:10.1007/s00253-016-7388-9. PMID: 26936774.
   PubMed Web of Science ®Google Scholar
• Durocher Y, Butler M. Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol. 2009;20:700–07. doi:10.1016/j.copbio.2009.10.008. PMID: 19889531.
   PubMed Web of Science ®Google Scholar
• Stadlmann J, Pabst M, Kolarich D, Kunert R, Altmann F. Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics. 2008;8(14):2858–71. doi:10.1002/pmic.200700968. PMID: 18655055.
   PubMed Web of Science ®Google Scholar
• Bosques CJ, Collins BE, Meador JW 3rd, Sarvaiya H, Murphy JL, Dellorusso G, Bulik DA, Hsu IH, Washburn N, Sipsey SF, et al. Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins. Nat Biotechnol. 2010;28(11):1153–56. doi:10.1038/nbt1110-1153. PMID: 21057479.
   PubMed Web of Science ®Google Scholar
• Hinterholzer A, Moises J, Regl C, Schwap S, Rapp E, Huber CG, Schubert M. Unambiguous identification of α-Gal epitopes in intact monoclonal antibodies by NMR spectroscopy. MAbs. 2022;14(1):2132977. doi:10.1080/19420862.2022.2132977. PMID: 36239533.
   PubMed Web of Science ®Google Scholar
• She YM, Dai S, Tam RY. Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry. Sci Rep. 2022;12(1):15109. doi:10.1038/s41598-022-19488-8. PMID: 36068283.
   PubMed Web of Science ®Google Scholar
• Maeda E, Kita S, Kinoshita M, Urakami K, Hayakawa T, Kakehi K. Analysis of nonhuman N-glycans as the minor constituents in recombinant monoclonal antibody pharmaceuticals. Anal Chem. 2012;84(5):2373–79. doi:10.1021/ac300234a. PMID: 22394092.
   PubMed Web of Science ®Google Scholar
• Galili U. The α-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie. 2001;83(7):557–63. doi:10.1016/s0300-9084(01)01294-9. PMID: 11522383.
   PubMed Web of Science ®Google Scholar
• Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov. 2009;8(3):226–34. doi:10.1038/nrd2804. PMID: 19247305.
   PubMed Web of Science ®Google Scholar
• Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A. 1993;90:11391–95. doi:10.1073/pnas.90.23.11391. PMID: 7504304.
   PubMed Web of Science ®Google Scholar
• Eisenson DL, Hisadome Y, Yamada K. Progress in xenotransplantation: immunologic barriers, advances in gene editing, and successful ^Tolerance induction strategies in pig-to-primate transplantation. Front Immunol. 2022;13:899657. doi:10.3389/fimmu.2022.899657. PMID: 35663933.
   PubMed Web of Science ®Google Scholar
• Commins SP, James HR, Kelly LA, Pochan SL, Workman LJ, Perzanowski MS, Kocan KM, Fahy JV, Nganga LW, Ronmark E, et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. J Allergy Clin Immunol. 2011;127(5):1286–93.e6. doi:10.1016/j.jaci.2011.02.019. PMID: 21453959.
   PubMed Web of Science ®Google Scholar
• Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, et al. Cetuximab-induced anaphylaxis and ige specific for galactose-α-1,3-galactose. N Engl J Med. 2008;358(11):1109–17. doi:10.1056/NEJMoa074943. PMID: 18337601.
   PubMed Web of Science ®Google Scholar
• van Bueren JJL, Rispens T, Verploegen S, van der Palen-Merkus T, Stapel S, Workman LJ, James H, van Berkel PH, van de Winkel JG, Platts-Mills TA, et al. Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains. Nat Biotechnol. 2011;29(7):574–76. doi:10.1038/nbt.1912. PMID: 21747378.
   PubMed Web of Science ®Google Scholar
• Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou Q. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem. 2007;364:8–18. doi:10.1016/j.ab.2007.01.023. PMID: 17362871.
   PubMed Web of Science ®Google Scholar
• Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, Baessmann C, Wagner-Rousset E, Suckau D, Beck A. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. MAbs. 2013;5:699–710. doi:10.4161/mabs.25423. PMID: 23924801.
   PubMed Web of Science ®Google Scholar
• Smith DF, Larsen RD, Mattox S, Lowe JB, Cummings RD. Transfer and expression of a murine UDP-Gal: beta-D-Gal-alpha 1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the alpha 1,3-galactosyltransferase and the endogenous alpha 2,3-sialyltransferase. J Biol Chem. 1990;265:6225–34. doi:10.1016/S0021-9258(19)39314-7. PMID: 2108155.
   PubMed Web of Science ®Google Scholar
• Cummings RD, Mattox SA. Retinoic acid-induced differentiation of the mouse teratocarcinoma cell line F9 is accompanied by an increase in the activity of UDP-galactose: beta-D-galactosyl-alpha 1,3-galactosyltransferase. J Biol Chem. 1988;263:511–19. doi:10.1016/S0021-9258(19)57422-1. PMID: 3121614.
   PubMed Web of Science ®Google Scholar
• Zhang P, Woen S, Wang T, Liau B, Zhao S, Chen C, Yang Y, Song Z, Wormald MR, Yu C, et al. Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. Drug Discov Today. 2016;21:740–65. doi:10.1016/j.drudis.2016.01.006. PMID: 26821133.
   PubMed Web of Science ®Google Scholar
• Garcia JJ, Raez LE, Rosas D. A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation. Transl Lung Cancer Res. 2020;9:2113–19. doi:10.21037/tlcr-20-601. PMID: 33209630.
   PubMed Web of Science ®Google Scholar
• Goel N, Chance K. Biosimilars in rheumatology: understanding the rigor of their development. Rheumatol (Oxford). 2017;56:187–97. doi:10.1093/rheumatology/kew206. PMID: 27241704.
   PubMed Web of Science ®Google Scholar
• Schiestl M, Stangler T, Torella C, Cepeljnik T, Toll H, Grau R. Acceptable changes in quality attributes of glycosylated biopharmaceuticals. Nat Biotechnol. 2011;29:310–12. doi:10.1038/nbt.1839. PMID: 21478841.
   PubMed Web of Science ®Google Scholar
• Wang LX, Tong X, Li C, Giddens JP, Li T. Glycoengineering of antibodies for modulating functions. Annu Rev Biochem. 2019;88:433–59. doi:10.1146/annurev-biochem-062917-012911. PMID: 30917003.
   PubMed Web of Science ®Google Scholar
• Parsons TB, Struwe WB, Gault J, Yamamoto K, Taylor TA, Raj R, Wals K, Mohammed S, Robinson CV, Benesch JL, et al. Optimal synthetic glycosylation of a therapeutic antibody. Angew Chem Weinheim Bergstr Ger. 2016;128:2407–13. doi:10.1002/ange.201508723. PMID: 27546920.
   PubMedGoogle Scholar
• Hatfield G, Tepliakova L, Gingras G, Stalker A, Li X, Aubin Y, Tam RY. Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcgammaRIIIA binding affinity. Front Immunol. 2022;13:972168. doi:10.3389/fimmu.2022.972168. PMID: 36304448.
   PubMed Web of Science ®Google Scholar
• Aoyama M, Hashii N, Tsukimura W, Osumi K, Harazono A, Tada M, Kiyoshi M, Matsuda A, Ishii-Watabe A. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies. MAbs. 2019;11(5):826–36. doi:10.1080/19420862.2019.1608143. PMID: 30990348.
   PubMed Web of Science ®Google Scholar
• Fan JQ, Kondo A, Kato I, Lee YC. High-performance liquid chromatography of glycopeptides and oligosaccharides on graphitized carbon columns. Anal Biochem. 1994;219:224–29. doi:10.1006/abio.1994.1261. PMID: 8080079.
   PubMed Web of Science ®Google Scholar
• She YM, Tam RY, Li X, Rosu-Myles M, Sauve S. Resolving isomeric structures of native glycans by nanoflow porous graphitized carbon chromatography–mass spectrometry. Anal Chem. 2020;92(20):14038–46. doi:10.1021/acs.analchem.0c02951. PMID: 32960038.
   PubMed Web of Science ®Google Scholar
• Elices MJ, Goldstein IJ. Biosynthesis of Bi-, Tri-, and tetraantennary oligosaccharides containing α-D-Galactosyl residues at their nonreducing termini. J Biol Chem. 1989;264(3):1375–80. doi:10.1016/S0021-9258(18)94197-9. PMID: 2492275.
   PubMed Web of Science ®Google Scholar
• Johnson LS, Braden B, inventors; MedImmune Inc., Bowie State University, assignees. Crystals and Structure of Synagis FAB. United States patent US 6,955,717 B2 2005 Oct 18.
   Google Scholar
• Li T, Tong X, Yang Q, Giddens JP, Wang LX. Glycosynthase mutants of endoglycosidase S2 show potent transglycosylation activity and remarkably relaxed substrate specificity for antibody glycosylation remodeling. J Biol Chem. 2016;291:16508–18. doi:10.1074/jbc.M116.738765. PMID: 27288408.
   PubMed Web of Science ®Google Scholar
• Mariotte D, Dupont B, Gervais R, Galais MP, Laroche D, Tranchant A, Comby E, Bouhier-Leporrier K, Reimund JM, Le Mauff B. Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis. MAbs. 2011;3:396–401. doi:10.4161/mabs.3.4.16293. PMID: 21654207.
   PubMed Web of Science ®Google Scholar
• Dupont B, Mariotte D, Dugue AE, Clarisse B, Grellard JM, Babin E, Chauffert B, Dakpe S, Moldovan C, Bouhier-Leporrier K, et al. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab. Br J Clin Pharmacol. 2017;83:623–31. doi:10.1111/bcp.13140. PMID: 27662818.
   PubMed Web of Science ®Google Scholar
• Serrier J, Davy JB, Dupont B, Clarisse B, Parienti JJ, Petit G, Khoy K, Ollivier Y, Gervais R, Mariotte D, et al. Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab. Bmc Cancer. 2023;23(1):32. doi:10.1186/s12885-023-10501-5. PMID: 36624467.
   PubMed Web of Science ®Google Scholar
• Fussl F, Trappe A, Carillo S, Jakes C, Bones J. Comparative elucidation of cetuximab heterogeneity on the intact protein level by cation exchange chromatography and capillary electrophoresis coupled to mass spectrometry. Anal Chem. 2020;92:5431–38. doi:10.1021/acs.analchem.0c00185. PMID: 32105056.
   PubMed Web of Science ®Google Scholar
• Lippold S, Nicolardi S, Wuhrer M, Falck D. Proteoform-resolved fcɤriiia binding assay for fab glycosylated monoclonal antibodies achieved by affinity chromatography mass spectrometry of Fc moieties. Front Chem. 2019;7:698. doi:10.3389/fchem.2019.00698. PMID: 31709228.
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Zauner G, Huhn C, Bruggink C, Deelder AM, Wuhrer M. Glycan labeling strategies and their use in identification and quantification. Anal Bioanal Chem. 2010;397:3457–81. doi:10.1007/s00216-010-3532-z. PMID: 20225063.
   PubMed Web of Science ®Google Scholar
• Smith SA, Chruszcz M, Chapman MD, Pomes A. Human monoclonal ige antibodies—a major milestone in allergy. Curr Allergy Asthma Rep. 2023;23(1):53–65. doi:10.1007/s11882-022-01055-w. PMID: 36459330.
   PubMedGoogle Scholar
• Wurth MA, Hadadianpour A, Horvath DJ, Daniel J, Bogdan O, Goleniewska K, Pomes A, Hamilton RG, Peebles RS Jr., Smith SA. Human IgE mAbs define variability in commercial Aspergillus extract allergen composition. JCI Insight. 2018;3. doi:10.1172/jci.insight.123387. PMID: 30333320.
   PubMed Web of Science ®Google Scholar
• Khatri K, Richardson CM, Glesner J, Kapingidza AB, Mueller GA, Zhang J, Dolamore C, Vailes LD, Wunschmann S, Peebles RS Jr., et al. Human IgE monoclonal antibody recognition of mite allergen Der p 2 defines structural basis of an epitope for IgE cross-linking and anaphylaxis in vivo. PNAS Nexus. 2022;1(3):c054. doi:10.1093/pnasnexus/pgac054. PMID: 35799831.
   Google Scholar
• Hadadianpour A, Daniel J, Zhang J, Spiller BW, Makaraviciute A, DeWitt AM, Walden HS, Hamilton RG, Peebles RS Jr., Nutman TB, et al. Human IgE mAbs identify major antigens of parasitic worm infection. J Allergy Clin Immunol. 2022;150(6):1525–33. doi:10.1016/j.jaci.2022.05.022. PMID: 35760390.
   PubMed Web of Science ®Google Scholar
• Savitz J, Geaney C, Banks TA. A case of anaphylaxis to palivizumab. Ann Allergy Asthma Immunol. 2014;113:236–37. doi:10.1016/j.anai.2014.06.006. PMID: 25065351.
   PubMed Web of Science ®Google Scholar
• Resch B. Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection. Hum Vaccin Immunother. 2017;13:2138–49. doi:10.1080/21645515.2017.1337614. PMID: 28605249.
   PubMed Web of Science ®Google Scholar
• Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein a from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 1981;20(9):2361–70. doi:10.1021/bi00512a001. PMID: 7236608.
   PubMed Web of Science ®Google Scholar
• Barb AW, Prestegard JH. NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat Chem Biol. 2011;7:147–53. doi:10.1038/nchembio.511. PMID: 21258329.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Kato K, Shindo M, Aoki S, Furusho K, Koga K, Takahashi N, Arata Y, Shimada I. Dynamics of the carbohydrate chains attached to the Fc portion of immunoglobulin G as studied by NMR spectroscopy assisted by selective 13C labeling of the glycans. J Biomol NMR. 1998;12:385–94. doi:10.1023/a:1008392229694. PMID: 9835046.
   PubMed Web of Science ®Google Scholar
• Barb AW, Brady EK, Prestegard JH. Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry. 2009;48:9705–07. doi:10.1021/bi901430h. PMID: 19772356.
   PubMed Web of Science ®Google Scholar
• Lungulescu CV, Ungureanu BS, Turcu-Stiolica A, Ghimpau V, Artene SA, Cazacu IM, Grecu AF, Dinescu VC, Croitoru A, Volovat SR. The role of IgE specific for galactose-α-1,3-galactose in predicting cetuximab induced hypersensitivity reaction: a systematic review and a diagnostic meta-analysis. Sci Rep. 2020;10(1):21355. doi:10.1038/s41598-020-78497-7. PMID: 33288791.
   PubMed Web of Science ®Google Scholar
• Subedi GP, Hanson QM, Barb AW. Restricted motion of the conserved immunoglobulin G1 N-Glycan is essential for efficient FcγRIIIa binding. Structure. 2014;22(10):1478–88. doi:10.1016/j.str.2014.08.002. PMID: 25199692.
   PubMed Web of Science ®Google Scholar
• Crispin M, Yu X, Bowden TA. Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy. Proc Natl Acad Sci U S A. 2013;110:E3544–3546. doi:10.1073/pnas.1310657110. PMID: 23929778.
   PubMed Web of Science ®Google Scholar
• Van Coillie J, Schulz MA, Bentlage AEH, de Haan N, Ye Z, Geerdes DM, van Esch WJE, Hafkenscheid L, Miller RL, Narimatsu Y, et al. Role of N-Glycosylation in FcgammaRIIIa interaction with IgG. Front Immunol. 2022;13:987151. doi:10.3389/fimmu.2022.987151. PMID: 36189205.
   PubMed Web of Science ®Google Scholar
• Li T, DiLillo DJ, Bournazos S, Giddens JP, Ravetch JV, Wang LX. Modulating IgG effector function by Fc glycan engineering. Proc Natl Acad Sci USA. 2017;114:3485–90. doi:10.1073/pnas.1702173114. PMID: 28289219.
   PubMed Web of Science ®Google Scholar
• Sjogren J, Struwe WB, Cosgrave EF, Rudd PM, Stervander M, Allhorn M, Hollands A, Nizet V, Collin M. EndoS2 is a unique and conserved enzyme of serotype M49 group a Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein. Biochem J. 2013;455(1):107–18. doi:10.1042/BJ20130126. PMID: 23865566.
   PubMedGoogle Scholar